Search

everythinglearnresearchcommunity

for

Search:↓

Increased TEMRA cells can predict treatment outcomes in rapidly progressive alopecia areata.

Using patients' own fat-derived cells to treat alopecia areata significantly improved hair growth and was safe.

Non-coding RNA boosts retinoic acid production and signaling, aiding regeneration.

Machine learning can help find new ways to treat alopecia areata.

Exosomes show promise as effective treatments for autoimmune skin diseases with fewer side effects.

Upadacitinib successfully regrew hair in a child with alopecia universalis and specific genetic mutations.

Tofacitinib helps hair regrow in some kids with severe alopecia areata, but more research is needed on long-term effects.

Chronic refractory alopecia areata has more skin-resident memory T cells, and JAK inhibitors may help reduce them.

Machine learning can help identify biomarkers for personalized Pemphigus vulgaris treatment.

Thymosin beta 4 protects cells from damage by blocking a harmful microRNA and boosting a protective gene.

The treatment effectively promotes hair regrowth in androgenetic alopecia without causing skin irritation.

Tea tree oil may help treat scalp alopecia by promoting hair follicle stem cell growth.

Tofacitinib was found to be a safe and effective treatment for hair regrowth in patients with alopecia areata.

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

Thrombospondin-1 is crucial for hair follicle regression and reduced blood vessel growth during the catagen phase.

New medicines that block a specific pathway are showing promise for treating severe hair loss but need more testing for safety and effectiveness.

Follicular microautotransplantation effectively improves scalp scars and enhances quality of life.

PCAT1 helps hair growth by controlling miR-329/Wnt10b.

Using truncal anesthesia on the supraorbital nerve reduces pain in hair loss treatments and improves patient comfort.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

Deucravacitinib led to full hair regrowth in a severe alopecia areata patient.

Tofacitinib treatment significantly improved a patient's psoriasis, psoriatic arthritis, and alopecia universalis.

Thymosin β4 may boost hair growth by aiding stem cell movement and blood vessel formation.

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

Tofacitinib helps mice grow more hair by increasing noggin and BMP4 levels, possibly better than minoxidil.

Tofacitinib significantly regrows hair in severe alopecia without major side effects.

A new compound shows promise as a topical treatment for hair loss.

Lysophospholipids can act as anti-inflammatory agents through specific receptors, but more research is needed.

The enzyme PA-PLA1α is important for proper hair follicle development.

LPAR6 has a unique way of binding and activating, which helps in designing treatments for hair loss and cancer.